Ratings by Litchfield Hills Research (Theodore O\'Neill)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/22/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2020 | UC Asset LP | UCASU | New Coverage | Buy (N/A) |
2.10 (0.49) |
-76.67% | Details | |
| 3/2/2020 | Co-Diagnostics | CODX | New Coverage | Buy (N/A) |
13.23 (1.14) |
-91.38% | Details | |
| 2/20/2020 | Digirad | DRAD | New Coverage | Buy (N/A) |
3.13 (3.59) |
14.7% | Details | |
| 12/16/2019 | Q BioMed | QBIO | New Coverage | Buy (N/A) |
1.46 (0.00) |
-100% | Details | |
| 11/13/2019 | Verb technology Co. Inc. | VERB | New Coverage | Buy (N/A) |
0.91 (0.18) |
-80.22% | Details | |
| 9/16/2019 | Bel Fuse | BELFA | New Coverage | Buy (N/A) |
14.61 (71.07) |
386.45% | Details | |
| 9/16/2019 | Bel Fuse | BELFB | New Coverage | Buy (N/A) |
15.13 (60.70) |
301.19% | Details |
